Jefferies Financial Group reiterated their buy rating on shares of Bridgepoint Group (LON:BPT – Free Report) in a report published on Tuesday morning, MarketBeat reports. They currently have a GBX 310 ($3.97) target price on the stock.
Separately, JPMorgan Chase & Co. decreased their target price on Bridgepoint Group from GBX 262 ($3.36) to GBX 259 ($3.32) and set a neutral rating on the stock in a report on Wednesday, April 3rd.
Get Our Latest Stock Report on Bridgepoint Group
Bridgepoint Group Stock Performance
About Bridgepoint Group
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Further Reading
- Five stocks we like better than Bridgepoint Group
- Conference Calls and Individual Investors
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Most Volatile Stocks, What Investors Need to Know
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.